Can Chemotherapy — Cure Cancer?

Curative intent means your oncologist is giving chemotherapy with the goal of eliminating all detectable disease. It describes the aim, not a guarantee. Whether that aim is achievable depends on your cancer type, its stage, its biology, and how your cancer responds to treatment. Your oncologist should be able to tell you, at the outset, whether your treatment is given with curative intent or a different goal — and it is a reasonable question to ask directly if no one has explained it.

The cancers most consistently given chemotherapy with curative intent include Hodgkin lymphoma, testicular cancer, Burkitt lymphoma, and certain acute leukaemias. Many childhood cancers — including acute lymphoblastic leukaemia — are also treated with elimination of disease as the primary aim. For most solid tumours in adults, including advanced breast, lung, and bowel cancers, the aim of chemotherapy shifts to control rather than elimination. Your oncologist will tell you which applies to your specific diagnosis and stage.

For many people, yes. Treatment aimed at controlling disease can add significant time and meaningfully improve daily life. NCCN and ASCO both recognise disease control as a legitimate and important treatment outcome. Whether the expected benefit is worth the side effects of chemotherapy is a decision that depends on your specific situation — your cancer, your values, and what matters most to you. That conversation with your oncologist is worth having clearly before you start.

Response is usually assessed through scans — most commonly a CT scan, and sometimes a PET-CT — taken after a set number of treatment cycles. Blood markers are also used for certain cancers. Your oncologist will tell you when the first assessment scan is planned and what they will be looking for. If the cancer has not responded, or has grown despite treatment, your oncologist will discuss alternative options with you at that point.

Yes. If disease that was not initially suitable for curative-intent treatment responds very well, your oncologist may reassess whether a more intensive aim becomes possible — for example, if the cancer shrinks enough to allow surgery to remove what remains. The reverse is also true: if a cancer does not respond as hoped, the aim may shift from control to symptom management. This is why regular assessment during treatment matters, and why telling your team how you feel between appointments matters too.

Remission means your scans and blood tests show no detectable cancer at that point in time. It does not mean cancer cells cannot return. Being told you are in remission after curative-intent treatment is a meaningful result — it means the treatment achieved its immediate aim — but your team will continue to monitor you over months and years. The question of what happens over time is separate from what the scans show today. Your oncologist will explain what the monitoring schedule looks like for your specific cancer.